Prestige Consumer Healthcare Inc. (PBH): Total Liabilities
$1.61B
As of 2026-03-31
$2.65B
As of 2026-06-30
-5.5%
3-year compound annual growth
-4.9%
5-year compound annual growth
-3.1%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $1.61B | +2.5% | 2026-05-14, Balance as of period end |
| 2025-03-31 | $1.57B | -5.8% | 2026-05-14, Balance as of period end |
| 2024-03-31 | $1.66B | -12.8% | 2025-05-09, Balance as of period end |
| 2023-03-31 | $1.91B | -8.9% | 2024-05-15, Balance as of period end |
| 2022-03-31 | $2.09B | +1.1% | 2023-05-05, Balance as of period end |
| 2021-03-31 | $2.07B | -11.6% | 2022-05-06, Balance as of period end |
| 2020-03-31 | $2.34B | -0.1% | 2021-05-07, Balance as of period end |
| 2019-03-31 | $2.35B | -9.2% | 2020-05-08, Balance as of period end |
| 2018-03-31 | $2.58B | -16.4% | 2019-05-13, Balance as of period end |
| 2017-03-31 | $3.09B | +40.1% | 2018-05-10, Balance as of period end |
| 2016-03-31 | $2.20B | +9.4% | 2017-05-17, Balance as of period end |
| 2015-03-31 | $2.01B | n/c | 2016-05-17, Balance as of period end |
| 2014-03-31 | $1.23B | -2.3% | 2015-05-14, Balance as of period end |
| 2013-03-31 | $1.26B | -6.9% | 2014-05-19, Balance as of period end |
| 2012-03-31 | $1.36B | +95.0% | 2013-05-17, Balance as of period end |
| 2011-03-31 | $695.09M | n/a | 2012-05-18, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.61B | +2.5% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $336.81M | -26.0% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $656.90M | +128.2% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.30B | -21.3% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.03B | +25.6% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $899.65M | +5.1% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $401.41M | +18.0% |
| Alkermes plc. (ALKS) | 2025-12-31 | $667.70M | +13.1% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.12B | +3.8% |
Compare PBH, ACAD, MDGL, INDV side by side · Screen every company in Pharmaceutical Preparations ↗